Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antibiotics and Surgical Site Infection in Expander Based Breast Reconstruction Trial (ASSERT) A Multi-institutional Randomized Controlled Trial to Determine the Optimal Antibiotic Prophylaxis for Tissue Expander-based Breast Reconstruction

NCT04631185 is registered in ClinicalTrials.gov with The Plastic Surgery Foundation as lead sponsor.

NCT NCT04631185
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04631185 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antibiotics and Surgical Site Infection in Expander Based Breast Reconstruction Trial (ASSERT) A Multi-institutional Randomized Controlled Trial to Determine the Optimal Antibiotic Prophylaxis for Tissue Expander-based Breast Reconstruction
Lead sponsor
The Plastic Surgery Foundation
Phase
Not applicable
Overall status
Completed
Start date
May 7, 2021
Completion date
May 20, 2024
Enrollment
235 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic use, breast reconstruction, surgical site infection